Navigation Links
Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations
Date:7/21/2008

PITTSBURGH, July 21 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) announced today the appointment of Daniel E. Crookshank as vice president - Investor Relations and as a member of the company's senior leadership team. Reporting to Chief Financial Officer Edward J. Borkowski, Crookshank is responsible for all investment community communication as well as for the development and direction of activities that proactively promote Mylan to the investment community.

"Dan has a well-deserved reputation as an outstanding, senior investor relations professional," said Mylan Vice Chairman and CEO Robert J. Coury. "His extensive international experience - together with his comprehensive knowledge of finance and solid accounting background - will serve the company well going forward. We're excited to have an individual with Dan's talents joining our Mylan team."

Crookshank served most recently as vice president - Investor Relations for Rockwell Collins, a global manufacturer of communications and aviation electronics solutions for commercial and military customers worldwide. During his 18-year career with Rockwell Collins and Rockwell International, he served in a number of increasingly responsible positions within Finance. Crookshank also completed accounting assignments with National Steel Corporation and H.J. Heinz Corporation. He began his business career with the public accounting firm Deloitte, Haskins & Sells, now Deloitte & Touche.

Crookshank earned a bachelor's degree in business administration from Robert Morris University and an MBA from the Katz Graduate School of Business at the University of Pittsburgh.

Mylan Inc., with operations in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit
2. MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors
3. Daniel Corcoran named President of Anthem Blue Cross and Blue Shield in Maine
4. HealthSouth Finalizes Sale of Corporate Campus to Daniel Corporation
5. Hiemstra Appoints Daniel C. Rosenman as Vice President of Research & Development
6. Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research
7. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
8. Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards
9. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
10. Global Health Trax Joins Fight Against Autism With Jenny McCarthy and Generation Rescue
11. Bernadette Peters Joins Board of Directors of Standing Tall, Innovative Program for Multiply Disabled Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 2017 , ... In the Health Care IT campaign, Robert Herjavec discusses health ... if you will be attacked, but when.” However, he and many others involved highlight ... , Improvements in auditing and monitoring have taken security in health care a very ...
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University Institute ... faculty engaged in or interested in palliative care education and research. The Symposium, ... in North County San Diego on Sept. 28 and 29, 2017, on the campus ...
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will ... the 2016 National Education Policy Center Bunkum Award. We invite you to enjoy our ... This year’s Bunkum winner is the Center for American Progress (CAP), for its report, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, ... a raffle. Throughout the month of February, patients who visit Hamlin Dental Group will ... a dinner for two at the Cheesecake Factory. , Tickets are available for ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Visiomed, the French leader in medical ... changing the landscape of healthcare with their innovative ... custom-made solutions. Recognizing the rising demand of self-monitoring ... without walls, Visiomed has launched BewellConnect, the most ... professionals that is empowering the lives of patients. ...
(Date:2/23/2017)... , Feb. 23, 2017  Genesis Healthcare Services has ... announcement was made by Bill Monast , President ... and Nathan Feltman , executives with Home ... Services, LLC. This acquisition helps Hospice ... of technology enabled durable medical equipment (DME) solutions for ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
Breaking Medicine Technology: